|
|---|
|
|
|
|
|
w*********7
发帖数: 2883 | 1 Drug developer Targacept Inc. (NASDAQ: TRGT) and partner AstraZeneca plc (
NYSE: AZN) today announced that they will not file for regulatory approval
on an anti-depressant drug called TC-5214 following a trial in which the
drug did no better than placebo. The writing has been on the wall on TC-5214
since an announcement in December that the drug had failed to meet its
endpoint in a phase II trial.
Targacept's CEO said that the company has been preparing for this
possibility and that it will announce its plans by the end of April. The
company has more than $225 million in cash available according to the CEO.
Targacept’s shares are down -27% at $5.41 in a 52-week range of $4.91-$27.
22. AstraZeneca’s shares are up about 0.4% at $45.58 in a 52-week range of
$40.89-$52.54.
这下彻底歇菜了 | s**********9
发帖数: 846 | 2 Lost $1150 on this garbage. |
|
|
|
|
|
